Write For Us

PBS NewsHour full episode, Dec. 30, 2022

Sponsored Post Vitamin D2 Canada Persia
68 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

ava
Published
Friday on the NewsHour, a congressional committee makes six years of former President Trump's tax returns public. The FDA is criticized for breaking protocol during its approval process for a new Alzheimer's drug. Plus, David Brooks and Jonathan Capehart weigh in on the biggest political headlines of 2022 and what to expect in the new year.

WATCH TODAY’S SEGMENTS:
News Wrap: Arrest made in killing of four Idaho students
https://www.youtube.com/watch?v=ZiNDnPd4mjI
What did we learn from Trump's tax returns?
https://www.youtube.com/watch?v=6w54hTnZJvc
FDA criticized for Alzheimer's drug approval process
https://www.youtube.com/watch?v=bdfcWMNYfJ0
Former Obama staffer raises ALS awareness after diagnosis
https://www.youtube.com/watch?v=Ai6PB30sx9k
NewsHour viewers reflect on the biggest moments of the year
https://www.youtube.com/watch?v=b8Q8YhR0-TU
Brooks and Capehart reflect on the year in politics
https://www.youtube.com/watch?v=oxm7UFv5qG8
Judy Woodruff's goodbye as she departs NewsHour anchor desk
https://www.youtube.com/watch?v=xzo_f92h4lQ

Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG
Find more from PBS NewsHour at https://www.pbs.org/newshour
Subscribe to our YouTube channel: https://bit.ly/2HfsCD6

Follow us:
TikTok: https://www.tiktok.com/@pbsnews
Twitter: http://www.twitter.com/newshour
Instagram: http://www.instagram.com/newshour
Facebook: http://www.pbs.org/newshour

Subscribe:
PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts
Newsletters: https://www.pbs.org/newshour/subscribe

00:00 - Intro
02:46 - College Murder
04:37 - News Wrap
09:03 - Trump’s Taxes
16:14 - Alzheimer’s Drug
22:11 - The Good Fight
27:46 - 2022 Reflections
32:50 - Brooks & Capehart
45:29 - Judy’s Farewell
Category
U.S. & Canada
Tags
PBS NewsHour, NewsHour episode, NewsHour episode today
Sign in or sign up to post comments.
Be the first to comment